These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1722219)

  • 1. Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.
    Bleul C; Müller M; Frank R; Gausepohl H; Koldovsky U; Mgaya HN; Luande J; Pawlita M; ter Meulen J; Viscidi R
    J Clin Microbiol; 1991 Aug; 29(8):1579-88. PubMed ID: 1722219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients.
    Nindl I; Benitez-Bribiesca L; Berumen J; Farmanara N; Fisher S; Gross G; Lopez-Carillo L; Müller M; Tommasino M; Vazquez-Curiel A
    Arch Virol; 1994; 137(3-4):341-53. PubMed ID: 7524466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
    Sasagawa T; Inoue M; Tanizawa O; Yutsudo M; Hakura A
    Jpn J Cancer Res; 1992 Jul; 83(7):705-13. PubMed ID: 1325428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
    Sun Y; Shah KV; Müller M; Muñoz N; Bosch XF; Viscidi RP
    J Clin Microbiol; 1994 Sep; 32(9):2216-20. PubMed ID: 7529250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
    Rosales R; López-Contreras M; Cortes RR
    J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer.
    Meschede W; Zumbach K; Braspenning J; Scheffner M; Benitez-Bribiesca L; Luande J; Gissmann L; Pawlita M
    J Clin Microbiol; 1998 Feb; 36(2):475-80. PubMed ID: 9466762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
    Müller M; Viscidi RP; Sun Y; Guerrero E; Hill PM; Shah F; Bosch FX; Muñoz N; Gissmann L; Shah KV
    Virology; 1992 Apr; 187(2):508-14. PubMed ID: 1312268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of seroreactive regions of the human papillomavirus type 16 protein E4, E6, E7 and L1.
    Müller M; Gausepohl H; de Martynoff G; Frank R; Brasseur R; Gissmann L
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2709-17. PubMed ID: 1701482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of seroreactive epitopes of human papillomavirus type 18 E7 protein by synthetic peptides.
    Krchnák V; Pistĕk T; Vágner J; Suchánková A; Kañka J; Ritterová L; Vonka V
    Acta Virol; 1993 Oct; 37(5):395-402. PubMed ID: 7514354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.
    Krchnák V; Vágner J; Suchánková A; Krcmár M; Ritterová L; Vonka V
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2719-24. PubMed ID: 2174961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; la Rosa GP; Hernández-Montes J; Pérez-Saldaña K; Tapia-Guerrero YS; Toledo-Guzmán ME; Santiago-Osorio E; Sanchez-Peña HI; Mora-García Mde L
    Virol J; 2011 Feb; 8():59. PubMed ID: 21306638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
    Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins.
    Chee YH; Namkoong SE; Kim DH; Kim SJ; Park JS
    Gynecol Oncol; 1995 May; 57(2):226-31. PubMed ID: 7729739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.
    Stacey SN; Eklund C; Jordan D; Smith NK; Stern PL; Dillner J; Arrand JR
    Oncogene; 1994 Feb; 9(2):635-45. PubMed ID: 7507231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
    Sun Y; Eluf-Neto J; Bosch FX; Muñoz N; Walboomers JM; Meijer CJ; Shah KV; Clayman B; Viscidi RP
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):935-40. PubMed ID: 10548324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic response in human papillomavirus-associated invasive cervical cancer.
    Viscidi RP; Sun Y; Tsuzaki B; Bosch FX; Muñoz N; Shah KV
    Int J Cancer; 1993 Nov; 55(5):780-4. PubMed ID: 8244575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.
    Onda T; Kanda T; Zanma S; Yasugi T; Watanabe S; Kawana T; Ueda K; Yoshikawa H; Taketani Y; Yoshiike K
    Int J Cancer; 1993 Jun; 54(4):624-8. PubMed ID: 8390409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
    Fisher SG; Benitez-Bribiesca L; Nindl I; Stockfleth E; Muller M; Wolf H; Perez-Garcia F; Guzman-Gaona J; Gutierrez-Delgado F; Irvin W; Gissmann L
    Gynecol Oncol; 1996 Apr; 61(1):73-8. PubMed ID: 8626121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of antibody against human papillomavirus type 16 E6 and E7 in patients with cervical cancer is independent of sequence variations.
    Nindl I; Zumbach K; Pawlita M; Teller K; Schneider A; Dürst M
    J Infect Dis; 2000 May; 181(5):1764-7. PubMed ID: 10783118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.